It surprises me that non-holders would still be following CCC.Surely it is time to give up any thought of putting your hard-earned in here.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025